Strategies And Challenges For Covid-19 Antibody Development

Strategies and Challenges for COVID-19 Antibody Development

Enhancing strategies for COVID-19 solutions in diagnosis, vaccine development and therapies

GenScript USA Inc.

COVID-19: Public Health and Scientific Challenges - Anthony Fauci, Director, NIAID

HIV Prevention Trials Network

Cambridge Conversations: Responding to the medical challenges of COVID-19

Cambridge Development & Alumni Relations

Day 4 - Grand Challenges in COVID-19 Treatment

Challenges of testing for COVID-19 antibodies

Click On Detroit | Local 4 | WDIV

Picking the best antibody therapeutic candidates to develop the most effective COVID-19 therapeutic

#115–David Watkins, PhD: Immunology, monoclonal antibodies, & vaccine strategies for COVID-19

Developing Antibodies for Covid-19

Bloomberg Technology

Detection Method for COVID-19 and Vaccine Development Progress

GenScript USA Inc.

Scientific strategies for combating coronavirus

Generation of SARS-CoV-2 Antibodies in Multiple Formats within 4 Weeks

Bio-Rad Laboratories

Developing strategies for future-proofed COVID-19 vaccines resistant to variants

Garvan Institute of Medical Research

Development of an Antibody Dependent Enhancement(ADE) Assay to Support SARS-CoV2 Vaccine Development

Celerion - Clinical Research

Challenges and Opportunities in the Use of Monoclonal Antibody Therapy for COVID-19

Diagnostic Strategy for the COVID-19 Pandemic – Bench to Bedside to Blueprint for Policymakers

Johns Hopkins Medicine

Moving forward with COVID-19: Trends and challenges in molecular testing

Practices for Improving the Use of COVID-19 Monoclonal Antibodies

Using cancer research strategies to develop an anti-coronavirus vaccine

SARS-CoV-2 Testing Methods

DiaSorin Molecular LLC